Kristin Clement, Ph.D.
CEO, Bio-Val Consulting
Home
About
Publications
Contact
More
2016
Clement, KH and Basinger WG, “Detection of the Degree of Exposure to Chemical Warfare Nerve Agents and Organophosphate Pesticides with Lateral Flow Assays.” U.S. Patent Application No. 10,288,614.
2013
Ionin, B, R Hopkins, B Pleune, G Sivko, F Reid, KH Clement, T Rudge, G Stark, A Innes, S Sari, T Guina, C Howard, J Smith, ML Swoboda, E Vert-Wong, V Johnson, G Nabors, and M Skiadopoulos. 2013. Evaluation of Immunogenicity and Efficacy of Biothrax® (Anthrax Vaccine Adsorbed) for Post-Exposure Prophylaxis. Microb Immun Vaccines. Manuscript in Press; Accepted with Revisions.
2010
Clement KH, TL Rudge Jr, HJ Mayfield, LA Carlton, A Hester, NA Niemuth, CL Sabourin, AM Brys, and CP Quinn. 2010. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro. Clin Vacc Immun. 17(11):1753-62
2008
Omland KS, AM Brys, D Lansky, KH Clement, and F Lynn. 2008. Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species. Clin Vacc Immun. 15(6): 946–953
2007
Campbell JD, KH Clement, SS Wasserman, S Donegan, L Chrisley, and KL Kotloff. 2007 Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults. Hum Vacc. 3(5):205-11
2003
Long KH, FJ Gomez, and SL Newman. 2003. Identification of Heat Shock Protein 60 as the ligand on Histoplasma capsulatum that Mediates Binding to Human Macrophage CD11/CD18 Receptors. J Exp Med. 170:487-494
